| dc.contributor.author | Yenerel, Mustafa Nuri | |
| dc.contributor.author | Byrd, John C. | |
| dc.contributor.author | Hillmen, Peter | |
| dc.contributor.author | Ghia, Paolo | |
| dc.contributor.author | Kater, Arnon P. | |
| dc.contributor.author | Chanan-Khan, Asher | |
| dc.contributor.author | Furman, Richard R. | |
| dc.contributor.author | O'Brien, Susan | |
| dc.contributor.author | Illes, Arpad | |
| dc.contributor.author | Kay, Neil | |
| dc.contributor.author | Garcia-Marco, Jose A. | |
| dc.contributor.author | Mato, Anthony | |
| dc.contributor.author | Pinilla-Ibarz, Javier | |
| dc.contributor.author | Seymour, John F. | |
| dc.contributor.author | Lepretre, Stephane | |
| dc.contributor.author | Stilgenbauer, Stephan | |
| dc.contributor.author | Robak, Tadeusz | |
| dc.contributor.author | Patel, Priti | |
| dc.contributor.author | Higgins, Kara | |
| dc.contributor.author | Sohoni, Sophia | |
| dc.contributor.author | Jurczak, Wojciech | |
| dc.date.accessioned | 2021-12-10T12:47:27Z | |
| dc.date.available | 2021-12-10T12:47:27Z | |
| dc.identifier.citation | Byrd J. C. , Hillmen P., Ghia P., Kater A. P. , Chanan-Khan A., Furman R. R. , O'Brien S., Yenerel M. N. , Illes A., Kay N., et al., "First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia", CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021 | |
| dc.identifier.issn | 2152-2650 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_d73b3c54-ac65-4675-815d-5f06f67820c6 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/174663 | |
| dc.language.iso | eng | |
| dc.subject | HEMATOLOJİ | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Hematoloji | |
| dc.subject | Onkoloji | |
| dc.subject | Oncology | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Hematology | |
| dc.subject | Health Sciences | |
| dc.title | First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia | |
| dc.type | Makale | |
| dc.relation.journal | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | |
| dc.contributor.department | Ohio State University At Marion , , | |
| dc.identifier.volume | 21 | |
| dc.contributor.firstauthorID | 2735940 | |